Minerva Neurosciences, Inc. (NERV) — research page
US · us-cm-kg/NASDAQ/NERV · as of 2026-11-08
Identity and listing
Minerva Neurosciences, Inc. is listed on NASDAQ under ticker NERV, with ISIN US6033802058 and LEI 54930017PANCHC5LYH79. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Massachusetts. The segment is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Minerva Neurosciences, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | NERV | source · 2026-11-08 |
| ISIN | US6033802058 | source · 2026-11-08 |
| LEI | 54930017PANCHC5LYH79 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Massachusetts | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 79 filings in the window 2025-11-08 to 2026-11-08, across 43 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-06 and is of type results, 2 days before the record date of 2026-11-08. The exchange median cadence gap is 6.0 days, the exchange median filings are 52, and the exchange median latency is 5.0 days, across 4359 NASDAQ issuers. The sector median cadence gap is 6.0 days, the sector median filings are 63.0, and the sector median latency is 4.0 days, across 526 issuers in 2834 Pharmaceutical Preparations.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 79 | 4 | 2 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-06 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-11-03 | directors_dealings | 4 | 4 |
| 2026-10-27 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
| 2026-08-20 | directors_dealings | 3 | 3 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Deloitte & Touche LLP, located in Boston, Massachusetts. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
Three research houses are named on the issuer's investor-relations page: H.C. Wainwright, Jefferies and Citizens.
| research house | analyst | source · read date |
|---|---|---|
| H.C. Wainwright | Douglas Tsao | issuer page · 2026-11-11 |
| Jefferies | Andrew Tsai | issuer page · 2026-11-11 |
| Citizens | Jason Butler | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001598646.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/NERV (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1598646/000119312526101117/nerv-20251231.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://minervaneurosciences.com/investors/stock-information/ (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NASDAQ/NERV (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US6033802058"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9c5605b5204bacd2.